{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:40:14Z","timestamp":1756183214666,"version":"3.44.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFD1800205"],"award-info":[{"award-number":["2021YFD1800205"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32473048"],"award-info":[{"award-number":["32473048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Vaccine adjuvants are now widely utilized in vaccine formulations. The IFN-Stimulated Genes (ISGs) family, play crucial roles in immune regulation and exhibit broad-spectrum antiviral activity. However, limited studies have investigated the potential of ISGs as vaccine adjuvants. Here, three swine ISGs fusion proteins were induced and purified from <jats:italic>Escherichia coli<\/jats:italic>, including IFITM1, IFITM3 and Viperin (sIFITM1, sIFITM3, and sViperin). Furthermore, sIFITM1, sIFITM3, and sViperin inhibited the replication of pseudorabies virus (PRV) in swine (PK-15 and 3D4\/21) and murine (NIH\/3\u202fT3 and C57\/B6-L) cells. Importantly, these fusion proteins effectively enhanced the immunogenicity of inactivated classical swine fever virus (CSFV) vaccine and improved the immune response in vaccinated mice. Our evidence indicates that, compared with the CSFV vaccine group, the co-administration of sIFITM1, sIFITM3, and sViperin with CSFV vaccine significantly improved humoral immunity, increased T lymphocyte proliferation in the spleen, and elevated serum IgG antibody levels. In conclusion, this study successfully prepared sIFITM1, sIFITM3, and sViperin fusion proteins, confirming their ability to inhibit PRV replication and suggesting their potential as vaccine adjuvants.<\/jats:p>","DOI":"10.3389\/fvets.2025.1661103","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:13:32Z","timestamp":1756181612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["sIFITM1, sIFITM3, and sViperin antiviral proteins as inactivated CSFV vaccine adjuvants"],"prefix":"10.3389","volume":"12","author":[{"given":"Shasha","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haobo","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22034\/iji.2023.94097.2284","article-title":"Vaccine adjuvants: selection criteria, mechanism of action associated with immune responses and future directions","volume":"20","author":"Habib","year":"2023","journal-title":"Iran J Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imm.13526","article-title":"Vaccines, adjuvants and key factors for mucosal immune response","volume":"167","author":"Correa","year":"2022","journal-title":"Immunology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2018.00014","article-title":"Recent advances in targeting CD8 T-cell immunity for more effective Cancer immunotherapy","volume":"9","author":"Durgeau","year":"2018","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"4","author":"Deming","year":"2007","journal-title":"PLoS Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.4049\/jimmunol.181.9.6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) Nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","article-title":"Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human Primates","volume":"2","author":"Wang","year":"2016","journal-title":"ACS Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e02015","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1016\/j.vaccine.2011.05.026","article-title":"Bis-(3\u2032,5\u2032)-cyclic dimeric adenosine monophosphate: strong Th1\/Th2\/Th17 promoting mucosal adjuvant","volume":"29","author":"Ebensen","year":"2011","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e3322","DOI":"10.1371\/journal.pntd.0003322","article-title":"HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model","volume":"8","author":"Batra","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.vaccine.2007.12.038","article-title":"Vaccine adjuvant systems containing monophosphoryl lipid a and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers","volume":"26","author":"Vandepapeliere","year":"2008","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1073\/pnas.0813390106","article-title":"Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.vaccine.2009.10.017","article-title":"Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"15ra5","DOI":"10.1126\/scitranslmed.3000624","article-title":"Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus","volume":"2","author":"Khurana","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.immuni.2008.03.014","article-title":"Vaccine adjuvants alter TCR-based selection thresholds","volume":"28","author":"Malherbe","year":"2008","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0264-410X(00)00499-0","article-title":"The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine","volume":"19","author":"Podda","year":"2001","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1517\/14712598.8.2.235","article-title":"Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients","volume":"8","author":"Beran","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/j.vaccine.2006.12.018","article-title":"The utility of ISCOMATRIX\u2122 adjuvant for dose reduction of antigen for vaccines requiring antibody responses","volume":"25","author":"Boyle","year":"2007","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1016\/j.vaccine.2009.01.040","article-title":"Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults","volume":"27","author":"Schwarz","year":"2009","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000484258","article-title":"Interferon-stimulated genes as enhancers of antiviral innate immune signaling","volume":"10","author":"Crosse","year":"2018","journal-title":"J Innate Immun"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"543444","DOI":"10.3389\/fimmu.2020.543444","article-title":"Current Progress on host antiviral factor IFITMs","volume":"11","author":"Ren","year":"2020","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1016\/j.jmb.2013.09.024","article-title":"IFITMs restrict the replication of multiple pathogenic viruses","volume":"425","author":"Perreira","year":"2013","journal-title":"J Mol Biol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"17261","DOI":"10.1074\/jbc.M112.438515","article-title":"Interferon-inducible transmembrane protein 3 (IFITM3) restricts Reovirus cell entry","volume":"288","author":"Anafu","year":"2013","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fimmu.2018.00228","article-title":"The host restriction factor interferon-inducible transmembrane protein 3 inhibits vaccinia virus infection","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.chom.2014.11.001","article-title":"IFITM proteins incorporated into HIV-1 Virions impair viral fusion and spread","volume":"16","author":"Compton","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1093\/infdis\/jiv255","article-title":"Interferon-induced transmembrane protein-mediated inhibition of host cell entry of Ebola viruses","volume":"212","author":"Wrensch","year":"2015","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza a H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e1002909","DOI":"10.1371\/journal.ppat.1002909","article-title":"Ifitm 3 limits the severity of acute influenza in mice","volume":"8","author":"Bailey","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.celrep.2016.05.074","article-title":"The IFITMs inhibit Zika virus replication","volume":"15","author":"Savidis","year":"2016","journal-title":"Cell Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e1001258","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza a virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41577-021-00626-8","article-title":"Lessons in self-defence: inhibition of virus entry by intrinsic immunity","volume":"22","author":"Majdoul","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3389\/fimmu.2019.02751","article-title":"Interferon-independent innate responses to cytomegalovirus","volume":"10","author":"Ashley","year":"2019","journal-title":"Front Immunol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/3-540-26764-6_1","article-title":"Viral entry","volume":"285","author":"Sieczkarski","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e1007925","DOI":"10.1371\/journal.ppat.1007925","article-title":"Macaque interferon-induced transmembrane proteins limit replication of SHIV strains in an envelope-dependent manner","volume":"15","author":"Sharma","year":"2019","journal-title":"PLoS Pathog"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jmb.2013.10.019","article-title":"The role of viperin in the innate antiviral response","volume":"426","author":"Helbig","year":"2014","journal-title":"J Mol Biol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.chom.2007.06.009","article-title":"The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts","volume":"2","author":"Wang","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.antiviral.2013.03.015","article-title":"Lovastatin treatment mitigates the pro-inflammatory cytokine response in respiratory syncytial virus infected macrophage cells","volume":"98","author":"Ravi","year":"2013","journal-title":"Antivir Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.antiviral.2013.08.012","article-title":"Increased hydroxymethylglutaryl coenzyme a reductase activity during respiratory syncytial virus infection mediates actin dependent inter-cellular virus transmission","volume":"100","author":"Ravi","year":"2013","journal-title":"Antivir Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000342473","article-title":"Replication of respiratory syncytial virus is inhibited by the host defense molecule Viperin","volume":"5","author":"McGillivary","year":"2013","journal-title":"J Innate Immun"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"15125","DOI":"10.1073\/pnas.011593298","article-title":"Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus","volume":"98","author":"Chin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e1003497","DOI":"10.1371\/journal.ppat.1003497","article-title":"Viperin regulates cellular lipid metabolism during human cytomegalovirus infection","volume":"9","author":"Seo","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"112806","DOI":"10.1016\/j.celrep.2023.112806","article-title":"STAT3 regulates antiviral immunity by suppressing excessive interferon signaling","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e1012461","DOI":"10.1371\/journal.ppat.1012461","article-title":"A small protein encoded by PCBP1-AS1 is identified AS a key regulator of influenza virus replication via enhancing autophagy","volume":"20","author":"Chi","year":"2024","journal-title":"PLoS Pathog"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.vetmic.2017.03.022","article-title":"Alpha\/beta interferon receptor deficiency in mice significantly enhances susceptibility of the animals to pseudorabies virus infection","volume":"203","author":"Wei","year":"2017","journal-title":"Vet Microbiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"768621","DOI":"10.3389\/fimmu.2022.768621","article-title":"Sleeping with the enemy? The current knowledge of piscine Orthoreovirus (PRV) immune response elicited to counteract infection","volume":"13","author":"Vallejos-Vidal","year":"2022","journal-title":"Front Immunol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-virology-011720-095930","article-title":"Viperin reveals its true function","volume":"7","author":"Rivera-Serrano","year":"2020","journal-title":"Annu Rev Virol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e1003124","DOI":"10.1371\/journal.ppat.1003124","article-title":"IFITM proteins restrict viral membrane Hemifusion","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41586-018-0238-4","article-title":"A naturally occurring antiviral ribonucleotide encoded by the human genome","volume":"558","author":"Gizzi","year":"2018","journal-title":"Nature"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2172-13-36","article-title":"Adjuvant effect of docetaxel on the immune responses to influenza a H1N1 vaccine in mice","volume":"13","author":"Chen","year":"2012","journal-title":"BMC Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.4049\/jimmunol.2400447","article-title":"IgG glycosylation: biomarker, functional modulator, and structural component","volume":"213","author":"Radovani","year":"2024","journal-title":"J Immunol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"779691","DOI":"10.3389\/fimmu.2022.779691","article-title":"Risk factors and biomarkers for immune-related adverse events: a practical guide to identifying high-risk patients and Rechallenging immune checkpoint inhibitors","volume":"13","author":"Chennamadhavuni","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1661103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:13:35Z","timestamp":1756181615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1661103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":55,"alternative-id":["10.3389\/fvets.2025.1661103"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1661103","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"article-number":"1661103"}}